MENU
+Compare
ADMA
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$16.02
Change
-$0.61 (-3.67%)
Capitalization
3.79B

ADMA ADMA Biologics Forecast, Technical & Fundamental Analysis

an operator of a specialty immune globulin, development and commercialization of human plasma and plasma-derived therapeutics

Industry Biotechnology
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ADMA with price predictions
Jan 08, 2025

ADMA's Stochastic Oscillator is remaining in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for ADMA crossed bearishly below the 50-day moving average on December 19, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for ADMA entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on ADMA as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ADMA just turned positive on January 03, 2025. Looking at past instances where ADMA's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADMA advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.340) is normal, around the industry mean (14.746). P/E Ratio (59.333) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). ADMA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (9.950) is also within normal values, averaging (264.084).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ADMA is expected to report earnings to fall 3.33% to 14 cents per share on March 20

ADMA Biologics ADMA Stock Earnings Reports
Q4'24
Est.
$0.14
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.03
Q4'23
Missed
by $0.11
The last earnings report on November 07 showed earnings per share of 15 cents, beating the estimate of 12 cents. With 3.06M shares outstanding, the current market capitalization sits at 3.79B.
A.I. Advisor
published General Information

General Information

an operator of a specialty immune globulin, development and commercialization of human plasma and plasma-derived therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
465 State Route 17
Phone
+1 201 478-5552
Employees
624
Web
https://www.admabiologics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NESYX59.460.50
+0.85%
Natixis US Equity Opportunities Y
BALCX34.710.22
+0.64%
American Funds American Balanced C
FSGAX48.370.30
+0.62%
Franklin Small-Mid Cap Growth Adv
EGINX31.920.09
+0.28%
Invesco EQV European Equity Investor
DPRSX12.150.03
+0.25%
Macquarie Global Listed Real Assets Inst

ADMA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with ATRA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-3.67%
ATRA - ADMA
44%
Loosely correlated
-16.09%
RCUS - ADMA
41%
Loosely correlated
-0.64%
TARS - ADMA
38%
Loosely correlated
-0.85%
ACLX - ADMA
37%
Loosely correlated
-0.79%
LOGC - ADMA
36%
Loosely correlated
+1.93%
More